The Evolving Regulatory Paradigm of AI in MedTech: A Review of Perspectives and Where We Are Today
Therapeutic Innovation & Regulatory Science · 2024-05 · 58 (3) · 456-464
DOI: 10.1007/s43441-024-00628-3 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Therapeutic Innovation & Regulatory Science, online erschienen am 25.03.2024. Verfasst von Karen Zhou und 1 weiteren Autor:innen. Beteiligte Einrichtung: Northeastern University, Toronto, ON, Canada. k.zhou@northeastern.edu. Hauptthemen laut MEDLINE: Artificial Intelligence. Die Arbeit wurde bisher 73-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Northeastern University USA.
Abstract (Originalsprache)
Artificial intelligence (AI)-enabled technologies in the MedTech sector hold the promise to transform healthcare delivery by improving access, quality, and outcomes. As the regulatory contours of these technologies are being defined, there is a notable lack of literature on the key stakeholders such as the organizations and interest groups that have a significant input in shaping the regulatory framework. This article explores the perspectives and contributions of these stakeholders in shaping the regulatory paradigm of AI-enabled medical technologies. The formation of an AI regulatory framework requires the convergence of ethical, regulatory, technical, societal, and practical considerations. These multiple perspectives contribute to the various dimensions of an evolving regulatory paradigm. From the global governance guidelines set by the World Health Organization (WHO) to national regulations, the article sheds light not just on these multiple perspectives but also on their interconnectedness in shaping the regulatory landscape of AI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Northeastern University, Toronto, ON, Canada. k.zhou@northeastern.edu.
- SoftwareCPR, Ottawa, ON, Canada.
ORCID-Profile: Karen Zhou
Förderung
- Northeastern University USA
Zitieren
APA
Zhou, K., & Gattinger, G. (2024). The Evolving Regulatory Paradigm of AI in MedTech: A Review of Perspectives and Where We Are Today. Therapeutic Innovation & Regulatory Science, 58(3), 456-464. https://doi.org/10.1007/s43441-024-00628-3
Vancouver
Zhou K, Gattinger G. The Evolving Regulatory Paradigm of AI in MedTech: A Review of Perspectives and Where We Are Today. Therapeutic Innovation & Regulatory Science. 2024;58(3):456-464. doi:10.1007/s43441-024-00628-3
BibTeX
@article{Zhou2024,
author = {Zhou, Karen and Gattinger, Ginny},
title = {The Evolving Regulatory Paradigm of AI in MedTech: A Review of Perspectives and Where We Are Today},
journal = {Therapeutic Innovation & Regulatory Science},
year = {2024},
volume = {58},
number = {3},
pages = {456--464},
doi = {10.1007/s43441-024-00628-3}
}
EUVIMED